Wing H. Leung
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activation.
Journal: The Journal of clinical investigation
Published: April 29, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.
Journal: Nature communications
Published: October 26, 2024
Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: September 27, 2024
Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on "KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression".
Journal: Clinical and molecular hepatology
Published: August 27, 2024
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma.
Journal: Nature communications
Published: October 31, 2022
SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression.
Journal: JHEP reports : innovation in hepatology
Published: April 12, 2022
UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma.
Journal: Oncotarget
Published: April 27, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026